Ghisallo Capital Management LLC Centessa Pharmaceuticals PLC Transaction History

Ghisallo Capital Management LLC

  • $1.03 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$10.99 - $17.54 $164,850 - $263,100
-15,000 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$16.7 - $23.11 $167,000 - $231,100
-10,000 Reduced 40.0%
15,000 $251,000
Q2 2021

Aug 16, 2021
BUY
$21.71 - $25.66 $542,750 - $641,500
25,000 New
25,000 $555,000

Others Institutions Holding CNTA

# of Institutions
108
Shares Held
118M
Call Options Held
5.9K
Put Options Held
53K
View Full List

About Centessa Pharmaceuticals plc

CNTA Quotes by TradingView
  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.61B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Ghisallo Capital Management LLC Portfolio

Follow Ghisallo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghisallo Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email